Cite
HARVARD Citation
Delany-Moretlwe, S. et al. (2018). Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet infectious diseases. 18 (11), pp. 1241-1250. [Online].